| ECS Botanics Holdings Ltd (ECS) ORDINARY FULLY PAID |
Health Care |
$8 |
Appendix 4E & Annual Report
|
29 Aug 2025 11:53AM |
$0.008 |
$0.005 |
fallen by
33.33%
|
|
ECS - Price-sensitive ASX Announcement
Full Release
Key Points
- ECS Botanics Holdings Ltd transitioned to a business-to-consumer strategy amid structural changes in the Australian market.
- The company recorded a substantial loss of $5.73 million for the financial year ending 30 June 2025, compared to a profit of $1.92 million in the previous year.
- Revenue decreased slightly by 3% to $19.4 million compared to the previous year.
- The company focused on expanding its infrastructure with the addition of Protective Cropping Enclosures and enhanced cultivation facilities.
- ECS advanced its product diversification strategy, enabled by a Victorian Government Manufacturing Grant.
- The company suffered from a 50% write-down in biomass value due to shifting market demand and quality standards.
- ECS fully impaired goodwill and intangible assets totalling $2.9 million as part of a financial reset.
- The company became fully ACO certified Organic in accordance with the Australian National Standard for Organic and Biodynamic Produce.
- ECS Botanics Holdings Ltd remains focused on expanding its export market presence, particularly in Germany and Poland.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ECS Botanics Holdings Ltd (ECS) ORDINARY FULLY PAID |
Health Care |
$8 |
Appendix 4E & Annual Report
|
29 Aug 2025 11:53AM |
$0.008 |
$0.005 |
fallen by
33.33%
|
|
ECS - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for ECS Botanics Holdings Ltd decreased by 3% in FY2025 compared to FY2024, totaling $19.4 million.
- The company reported a net loss before tax of $6.91 million, a significant decrease from the previous year's profit.
- ECS Botanics faced challenges due to structural changes in the domestic market, affecting its B2B strategy.
- The company's EBITDA fell by 262%, reflecting the financial difficulties faced during FY2025.
- Majority of ECS Botanics' revenue came from the Medicinal Cannabis segment, with key customers contributing 26% to total revenue.
- The company made significant investments in property, plant, and equipment, reflected in increased depreciation expenses.
- ECS Botanics Holdings Ltd's cash and cash equivalents diminished substantially, reflecting financial strains.
- The company's issued capital increased due to the conversion of performance rights during the year.
- Directors and key management personnel had varied changes in fixed and variable remuneration components.
- There was no current on-market buy-back, and the group holds no franking credits.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Livium Ltd (LIT) ORDINARY FULLY PAID |
Industrials |
$19 |
Corporate Governance Statement
|
29 Aug 2025 11:51AM |
$0.012 |
$0.009 |
fallen by
25%
|
|
| Aspermont Limited (ASP) ORDINARY FULLY PAID |
Communication Services |
$18 |
Share Purchase Plan Booklet
|
29 Aug 2025 11:51AM |
$0.010 |
$1.570 |
risen by
15,600%
|
|
ASP - Price-sensitive ASX Announcement
Full Release
Key Points
- Eligible Shareholders can apply for new shares between A$2,000 and A$30,000 without incurring brokerage costs.
- The issue price is A$0.007 per Share, with a plan to raise approximately A$1.25 million.
- The Offer is non-underwritten, but Aspermont may conduct a shortfall placement with professional investors.
- The funds will be used to scale the Mining-IQ platform, invest in digitisation and AI initiatives, and maintain financial flexibility.
- The Share Purchase Plan is governed by ASIC Corporations Instrument 2019/547 and does not require a prospectus.
- New Shares will rank equally with existing shares, including dividend and voting rights from the date of issue.
- The Offer is open between 1 September 2025 and 15 September 2025, with shares allotted on 18 September 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aspermont Limited (ASP) ORDINARY FULLY PAID |
Communication Services |
$18 |
Share Purchase Plan Booklet
|
29 Aug 2025 11:51AM |
$0.010 |
$1.570 |
risen by
15,600%
|
|
ASP - Price-sensitive ASX Announcement
Full Release
Key Points
- Share Purchase Plan offered at A$0.007 per share.
- SPP not underwritten, targeting a raise of approximately A$1.25 million.
- Offer open to eligible shareholders from 1 to 15 September 2025.
- Funds to support growth initiatives including Mining-IQ platform and digitisation.
- Maximum application per shareholder is A$30,000.
- New shares will rank equally with existing shares post allotment.
- Funds to maintain Aspermont’s financial flexibility.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tissue Repair Ltd (TRP) ORDINARY FULLY PAID |
Health Care |
$7 |
Appendix 4G and Corporate Governance Statement
|
29 Aug 2025 11:50AM |
$0.300 |
$0.120 |
fallen by
60%
|
|
| Infinity Mining Limited (IMI) ORDINARY FULLY PAID |
Materials |
$4 |
Results of Annual General Meeting
|
29 Aug 2025 11:50AM |
$0.008 |
$0.008 |
fallen by
0%
|
|
| Livium Ltd (LIT) ORDINARY FULLY PAID |
Industrials |
$19 |
Appendix 4G
|
29 Aug 2025 11:50AM |
$0.012 |
$0.009 |
fallen by
25%
|
|
| Australian Agricultural Projects Limited (AAP) ORDINARY FULLY PAID |
Consumer Staple |
$27 |
Full year 2024/2025 Financial Results and Operating Review
|
29 Aug 2025 11:50AM |
$0.047 |
$0.074 |
risen by
57.45%
|
|
AAP - Price-sensitive ASX Announcement
Full Release
Key Points
- The company's profit after tax for the year was $1,960,060.
- Total revenue from lease and management fees increased by 18% from the previous year.
- The 2025 harvest yielded 752,600 litres of olive oil, affected by a frost event in September 2024.
- Net cash flows from operations resulted in a surplus of $929,850.
- The company revalued its orchard assets upwards by $965,177.
- The company's balance sheet showed an increase in net assets by $2,683,943.
- Increased retail shelf prices benefitted the company, with discussions ongoing for extending an olive oil supply agreement.
- Operating costs increased due to refurbishment and longer harvest periods.
- The company plans to farm a portion of the orchard for its own benefit after certain lease agreements expired.
- The outlook for the company remains positive with expected increases in harvest volumes and strong olive oil prices.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Agricultural Projects Limited (AAP) ORDINARY FULLY PAID |
Consumer Staple |
$27 |
Full year 2024/2025 Financial Results and Operating Review
|
29 Aug 2025 11:50AM |
$0.047 |
$0.074 |
risen by
57.45%
|
|
AAP - Price-sensitive ASX Announcement
Full Release
Key Points
- Profit after tax of $1,960,060 for the year ended 30 June 2025.
- 752,600 litres harvested in 2025, boosted by high olive oil prices.
- Frost event in September 2024 reduced harvest yield by over 10%.
- Net cash flows improved to a surplus of $929,850.
- Enhanced balance sheet by reducing liabilities by $1,176,761.
- Lease over VOOP terminated; Company to farm for own benefit.
- Positive outlook with increased harvest volumes and high olive oil prices.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Investor Centre Limited (ICU) ORDINARY FULLY PAID |
Financials |
$0 |
Delay in Release of Appendix 4E and Annual Report
|
29 Aug 2025 11:49AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
ICU - Price-sensitive ASX Announcement
Full Release
Key Points
- Delay in release of Appendix 4E and Annual Report for year ended 30 June 2025.
- Funding issues due to liquidation of Amram Corp Pty Ltd.
- Seeking alternative funding to meet financial obligations.
- Anticipated trading suspension from 1 September 2025.
- Commitment to continuous disclosure and shareholder updates.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Agricultural Projects Limited (AAP) ORDINARY FULLY PAID |
Consumer Staple |
$27 |
Preliminary Final Report
|
29 Aug 2025 11:48AM |
$0.047 |
$0.074 |
risen by
57.45%
|
|
AAP - Price-sensitive ASX Announcement
Full Release
Key Points
- The financial report is for the year ended 30 June 2025.
- Revenue from ordinary activities increased by 18% to $5,596,000.
- Net profit attributable to members rose by 56% to $1,960,060.
- No dividends were declared for the reporting period.
- The company operates a single segment which is an olive orchard located in Boort, Victoria.
- Net tangible asset backing per ordinary security increased to 4.16 cents.
- Total comprehensive income for the year was $2,683,943.
- The company incurred no share issues or options as of 30 June 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Agricultural Projects Limited (AAP) ORDINARY FULLY PAID |
Consumer Staple |
$27 |
Preliminary Final Report
|
29 Aug 2025 11:48AM |
$0.047 |
$0.074 |
risen by
57.45%
|
|
AAP - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from ordinary activities increased by 18% to $5,596,000.
- Net profit attributable to members increased by 56% to $1,960,060.
- No dividends were declared or paid during the period.
- Total assets stood at $23,890,058 with total liabilities of $8,544,934.
- Net cash provided by operating activities was $929,850, indicating improved cash flow management.
- The company maintained the same number of fully paid ordinary shares with no options on issue as of 30 June 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tissue Repair Ltd (TRP) ORDINARY FULLY PAID |
Health Care |
$7 |
Appendix 4E and Annual Report 30 June 2025
|
29 Aug 2025 11:47AM |
$0.300 |
$0.120 |
fallen by
60%
|
|
TRP - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss after income tax of AUD 4,238,501.
- Revenue and other income rose to AUD 3,220,107.
- Total expenses increased to AUD 7,458,608.
- Net assets reduced to AUD 13,911,558.
- No dividends declared during the year.
- Share-based payment expenses recognized.
- Focus on obtaining value from assets with no immediate dividend plans.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tissue Repair Ltd (TRP) ORDINARY FULLY PAID |
Health Care |
$7 |
Appendix 4E and Annual Report 30 June 2025
|
29 Aug 2025 11:47AM |
$0.300 |
$0.120 |
fallen by
60%
|
|
TRP - Price-sensitive ASX Announcement
Full Release
Key Points
- Tissue Repair Ltd aims to expand its TR Pro+® line globally and has retained rights to its medical TR Pro+® line.
- The company is preparing for a domestic launch targeting pharmacies, aged care, and healthcare providers.
- New multi-year distribution agreements have been secured in Australia and Thailand.
- TR Pro+® achieved strong sales growth with Q2 revenue reaching 112% of Q1.
- Regulatory submissions for U.S. FDA 510(k) and CE Mark are underway with approvals expected within 12 months.
- The company maintains a strong cash position with $12,318,476 as of 30 June 2025.
- The annual loss after tax for the year was $4,238,501, an increase of 2.4% from the previous year.
- Tissue Repair Ltd is progressing its clinical trials for TR987® and expanding its production capacity for Glucoprime® API.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Camplify Holdings Limited (CHL) ORDINARY FULLY PAID |
Industrials |
$15 |
Change of Director's Interest Notice
|
29 Aug 2025 11:47AM |
$0.500 |
$0.185 |
fallen by
63%
|
|
| Australian Agricultural Company Limited (AAC) ORDINARY FULLY PAID |
Consumer Staple |
$808 |
AACo Secures Refinance of Club Debt Facilities
|
29 Aug 2025 11:46AM |
$1.420 |
$1.340 |
fallen by
5.63%
|
|
| New Zealand King Salmon Investments Limited (NZK) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Staple |
$102 |
NZK Half Year Results Announcement Details
|
29 Aug 2025 11:46AM |
$0.185 |
$0.190 |
risen by
2.70%
|
|
| Pengana Global Private Credit Trust (PCX) ORDINARY UNITS FULLY PAID |
Financials |
$230 |
Appendix 4G 2025
|
29 Aug 2025 11:45AM |
$2.135 |
$2.030 |
fallen by
4.92%
|
|
| Axtec Limited (AXI) ORDINARY FULLY PAID |
Real Estate |
$7 |
Annual Report to shareholders
|
29 Aug 2025 11:45AM |
$0.021 |
$0.013 |
fallen by
38.10%
|
|
AXI - Price-sensitive ASX Announcement
Full Release
Key Points
- Consolidated loss of AUD 2.359 million for the year.
- Segment revenue from property and technology operations.
- Net assets valued at AUD 8.093 million as of 30 June 2025.
- Investment in Point Data Holdings Ltd with one-third ownership.
- Top 20 shareholders own 87.52% of the shares.
- Major shareholder Peter Laurance holds 23.62%.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Axtec Limited (AXI) ORDINARY FULLY PAID |
Real Estate |
$7 |
Annual Report to shareholders
|
29 Aug 2025 11:45AM |
$0.021 |
$0.013 |
fallen by
38.10%
|
|
AXI - Price-sensitive ASX Announcement
Full Release
Key Points
- Axiom Properties Limited reported a significant decrease in net assets from $10,452,000 in 2024 to $8,093,000 in 2025.
- The company experienced a net loss of $2,359,000 for the year ending 30 June 2025.
- There was no cash bonus paid to key management personnel in FY2025.
- The company’s issued capital remained unchanged at $30,641,000 for both 2024 and 2025.
- Axiom Properties Limited's total liabilities decreased from $8,175,000 in 2024 to $7,230,000 in 2025.
- The number of shares held by the top 20 shareholders constituted 87.52% of the total shareholdings as of 24 August 2025.
- No new shares were issued to key management personnel during the year ended 30 June 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana Global Private Credit Trust (PCX) ORDINARY UNITS FULLY PAID |
Financials |
$230 |
Corporate Governance Statement 2025
|
29 Aug 2025 11:45AM |
$2.135 |
$2.030 |
fallen by
4.92%
|
|
| Pengana Global Private Credit Trust (PCX) ORDINARY UNITS FULLY PAID |
Financials |
$230 |
Appendix 4E and Annual Report 30 June 2025
|
29 Aug 2025 11:44AM |
$2.135 |
$2.030 |
fallen by
4.92%
|
|
| Southern Cross Media Group Limited (SXL) ORDINARY FULLY PAID |
Communication Services |
$256 |
Updated Securities Trading Policy
|
29 Aug 2025 11:42AM |
$0.865 |
$0.535 |
fallen by
38.15%
|
|
| Livium Ltd (LIT) ORDINARY FULLY PAID |
Industrials |
$19 |
Annual Report
|
29 Aug 2025 11:42AM |
$0.012 |
$0.009 |
fallen by
25%
|
|
Call 1300 880 160
Start a chat
Schedule a call
